B. Braakhuis

M. Rietbergen, C. R. Leemans, P. Snijders, 2014, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

Second field tumors: a new opportunity for cancer prevention?

C. R. Leemans, R. Brakenhoff, B. Braakhuis, 2005, The oncologist.

Anticancer activity and mechanism of action of retinoids in oral and pharyngeal cancer.

B. Braakhuis, I. Klaassen, 2002, Oral oncology.

Expression of retinoic acid receptor gamma correlates with retinoic acid sensitivity and metabolism in head and neck squamous cell carcinoma cell lines

G. Snow, R. Brakenhoff, B. Braakhuis, 2001, International journal of cancer.

Metabolism and growth inhibition of four retinoids in head and neck squamous normal and malignant cells

G. Snow, R. Brakenhoff, B. Braakhuis, 2001, British Journal of Cancer.

Enhanced turnover of all-trans-retinoic acid and increased formation of polar metabolites in head and neck squamous cell carcinoma lines compared with normal oral keratinocytes.

G. Snow, R. Brakenhoff, B. Braakhuis, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

Mutagen sensitivity as a biomarker for second primary tumors after head and neck squamous cell carcinoma.

G. Snow, D. Kuik, C. Leemans, 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Plasma retinoid levels in head and neck cancer patients: a comparison with healthy controls and the effect of retinyl palmitate treatment.

G. Snow, B. Braakhuis, T. Teerlink, 1999, Oral oncology.

Considerations for in vitro retinoid experiments: importance of protein interaction.

G. Snow, R. Brakenhoff, B. Braakhuis, 1999, Biochimica et biophysica acta.

Retinoid metabolism and all-trans retinoic acid-induced growth inhibition in head and neck squamous cell carcinoma cell lines.

G. Snow, H. Hendriks, R. Brakenhoff, 1997, British Journal of Cancer.

All-trans retinoic acid induced gene expression and growth inhibition in head and neck cancer cell lines.

G. Snow, R. Brakenhoff, J. Cloos, 1997, Oral oncology.

The relation between cancer incidence among relatives and the occurrence of multiple primary carcinomas following head and neck cancer.

H. Tobi, G. Snow, V. Bongers, 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Relationship between the parameters cellular differentiation, doubling time and platinum accumulation and cisplatin sensitivity in a panel of head and neck cancer cell lines

M. Welters, R. Baan, M. Hermsen, 1997, International journal of cancer.

Involvement of cell cycle control in bleomycin‐induced mutagen sensitivity

C. Leemans, J. Cloos, B. Braakhuis, 2002, Environmental and molecular mutagenesis.

Molecular screening of oral precancer.

C. R. Leemans, M. de Maaker, E. Bloemena, 2013, Oral oncology.

Localization and imaging of radiolabelled monoclonal antibody against squamous‐cell carcinoma of the head and neck in tumor‐bearing nude mice

G. Snow, C. Meijer, A. Balm, 1989, International journal of cancer.

Schedule-dependent antitumor effect of gemcitabine in in vivo model system.

G. Peters, B. Braakhuis, E. Boven, 1995, Seminars in oncology.

Molecular and health effects in the upper respiratory tract associated with tobacco smoking other than cigarettes

E. Florek, B. Braakhuis, C. Silver, 2018, International journal of cancer.

Increasing prevalence rates of HPV attributable oropharyngeal squamous cell carcinomas in the Netherlands as assessed by a validated test algorithm

M. Rietbergen, C. R. Leemans, C. Meijer, 2013, International journal of cancer.

Quantitative Diffusion-WeightedMRI Parameters and Human Papillomavirus Status in Oropharyngeal Squamous Cell Carcinoma

C. R. Leemans, E. Bloemena, J. Castelijns, 2015 .

Cancer stem cell enrichment marker CD98: a prognostic factor for survival in patients with human papillomavirus-positive oropharyngeal cancer.

M. Rietbergen, C. R. Leemans, E. Bloemena, 2014, European journal of cancer.

Treatment choice for locally advanced head and neck cancers on the basis of risk factors: biological risk factors.

C. R. Leemans, R. Brakenhoff, B. Braakhuis, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

De-escalation studies in HPV-positive oropharyngeal cancer: How should we proceed?

A. Sanabria, R. de Bree, A. Mäkitie, 2021, Oral oncology.

Treatment response of HPV-positive and HPV-negative head and neck squamous cell carcinoma cell lines.

Remco Nagel, Sanne R. Martens-de Kemp, R. Brakenhoff, 2013, Oral oncology.

Human papilloma virus in head and neck cancer: the need for a standardised assay to assess the full clinical importance.

C. R. Leemans, C. Meijer, P. Snijders, 2009, European journal of cancer.

Expression signature in peripheral blood cells for molecular diagnosis of head and neck squamous cell carcinoma.

C. R. Leemans, B. Ylstra, W. V. van Wieringen, 2013, Oral diseases.

Second primary tumors and field cancerization in oral and oropharyngeal cancer: molecular techniques provide new insights and definitions.

C. R. Leemans, G. Snow, R. Brakenhoff, 2002, Head & neck.

DNA‐damage processing in blood lymphocytes of head‐and‐neck‐squamous‐cell‐carcinoma patients is dependent on tumor site

G. Snow, J. Cloos, B. Braakhuis, 1996, International journal of cancer.

Evaluation of cornulin, keratin 4, keratin 13 expression and grade of dysplasia for predicting malignant progression of oral leukoplakia.

A. Heck, M. Slijper, R. Brakenhoff, 2010, Oral oncology.

Electronic Cigarettes and Head and Neck Cancer Risk—Current State of Art

A. Mäkitie, E. Florek, P. Strojan, 2020, Cancers.

Response to correspondence on the molecular biology of head and neck cancer

C. R. Leemans, R. Brakenhoff, B. Braakhuis, 2011, Nature Reviews Cancer.

Antitumor activity of prolonged as compared with bolus administration of 2′,2′-difluorodeoxycytidine in vivo against murine colon tumors

G. Peters, H. Pinedo, B. Braakhuis, 1996, Cancer Chemotherapy and Pharmacology.

Radioimmunotherapy of human head and neck squamous cell carcinoma xenografts with 131I-labelled monoclonal antibody E48 IgG.

M. Gerretsen, G. Snow, G. V. van Dongen, 1992, British Journal of Cancer.

The FA/BRCA Pathway Identified as the Major Predictor of Cisplatin Response in Head and Neck Cancer by Functional Genomics

C. R. Leemans, Sanne R. Martens-de Kemp, R. D. de Menezes, 2016, Molecular Cancer Therapeutics.

Mutagen sensitivity in patients with familial and non‐familial urothelial cell carcinoma

L. Kiemeney, K. Aben, J. Witjes, 2000, International journal of cancer.

Discordance of genetic alterations between primary head and neck tumors and corresponding metastases associated with mutational status of the TP53 gene

C. R. Leemans, G. Snow, R. Brakenhoff, 2002, Genes, chromosomes & cancer.

Pretreatment deoxycytidine kinase levels predict in vivo gemcitabine sensitivity.

G. Peters, I. Talianidis, C. L. van der Wilt, 2002, Molecular cancer therapeutics.

Enhanced therapeutic efficacy of 5'deoxy-5-fluorouridine in 5-fluorouracil resistant head and neck tumours in relation to 5-fluorouracil metabolising enzymes.

G. Peters, M. van Walsum, H. Pinedo, 1989, British Journal of Cancer.

Screening for Oral Precancer with Noninvasive Genetic Cytology

C. R. Leemans, D. Kuik, E. Bloemena, 2009, Cancer Prevention Research.

Role of glutathione, glutathione S-transferases and multidrug resistance-related proteins in cisplatin sensitivity of head and neck cancer cell lines.

M. Welters, R. Baan, M. Flens, 1998, British Journal of Cancer.

Potential for targeting head and neck squamous cell carcinoma with monoclonal antibody K984

M. Gerretsen, G. Snow, B. Braakhuis, 1992, Cancer Immunology, Immunotherapy.

Mutagen sensitivity: enhanced risk assessment of squamous cell carcinoma.

G. Snow, J. Cloos, B. Braakhuis, 1996, European journal of cancer. Part B, Oral oncology.

Schedule-dependent therapeutic efficacy of the combination of gemcitabine and cisplatin in head and neck cancer xenografts.

G. Peters, M. Welters, B. Braakhuis, 1995, European journal of cancer.

POTENTIAL EARLY MARKERS OF CARCINOGENESIS IN THE MUCOSA OF THE HEAD AND NECK USING EXFOLIATIVE CYTOLOGY

G. Snow, V. Bongers, B. Braakhuis, 1996, The Journal of pathology.

Second primary head and neck squamous cell carcinoma predicted by the glutathione S-transferase expression in healthy tissue in the direct vicinity of the first tumor.

G. Snow, N. de Vries, V. Bongers, 1995, Laboratory investigation; a journal of technical methods and pathology.

Lack of effect of daily N-acetylcysteine supplementation on mutagen sensitivity.

Value of p53 expression in oral cancer and adjacent normal mucosa in relation to the occurrence of multiple primary carcinomas.

G. Snow, V. Bongers, B. Braakhuis, 1995, European journal of cancer. Part B, Oral oncology.

Prognostic value of DNA ploidy status in patients with oral leukoplakia.

C. R. Leemans, E. Bloemena, J. Beliën, 2011, Oral oncology.

Preclinical in vivo activity of 2',2'-difluorodeoxycytidine (Gemcitabine) against human head and neck cancer.

G. Snow, G. V. van Dongen, B. Braakhuis, 1991, Cancer research.

In vitro antiproliferative and metabolic activity of eight novel 5-fluorinated uracil nucleosides.

G. Peters, B. Braakhuis, G. Visser, 1991, European journal of cancer.

Improved 32P-postlabelling assay for the quantification of the major platinum-DNA adducts.

M. Welters, R. Baan, J. Schellens, 1997, Carcinogenesis.

The potential of plantinum-DNA adduct determination in ex vivo treated tumor fragments for the prediction of sensitivity to cisplatin chemotherapy.

M. Welters, R. Baan, B. Braakhuis, 1999, Annals of oncology : official journal of the European Society for Medical Oncology.

Increased mutagen sensitivity in head‐and‐neck squamous‐cell carcinoma patients, particularly those with multiple primary tumors

G. Snow, N. de Vries, J. Cloos, 1994, International journal of cancer.

Preclinical phase II studies in human tumor xenografts: a European multicenter follow-up study.

O. Fodstad, S. Langdon, H. Fiebig, 1994, Annals of oncology : official journal of the European Society for Medical Oncology.

Addition of leucovorin in modulation of 5‐fluorouracil with methotrexate: Potentiating or reversing effect?

G. Peters, C. L. van der Wilt, H. Pinedo, 1995, International journal of cancer.

A comparison of bleomycin-induced damage in lymphocytes and primary oral fibroblasts and keratinocytes in 30 subjects.

H. Tobi, G. Snow, C. Leemans, 1999, Mutagenesis.

A comprehensive assessment protocol including patient reported outcomes, physical tests, and biological sampling in newly diagnosed patients with head and neck cancer: is it feasible?

R. de Bree, C. Leemans, I. V. Verdonck‐de Leeuw, 2014, Supportive Care in Cancer.

Anti‐tumor and differentiation‐inducing activity of n,n‐dimethylformamide (dmf) in head‐and‐neck cancer xenografts

G. Snow, G. V. van Dongen, B. Braakhuis, 1989, International journal of cancer.

An optimized synthesis of 18F-labelled 5-fluorouracil and a reevaluation of its use as a prognostic agent

B. Braakhuis, J. Herscheid, G. Visser, 2004, European Journal of Nuclear Medicine.

Centromeric breakage as a major cause of cytogenetic abnormalities in oral squamous cell carcinoma

M. Welters, H. Joenje, M. Hermsen, 1996, Genes, chromosomes & cancer.

Growth of xenografted squamous cell carcinoma of the head and neck ‐ possible correlation with patient survival

B. Braakhuis, G. Dongen, R. Attewell, 1992, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

Second primary tumors and field cancerization in oral and oropharyngeal cancer: Molecular techniques provide new insights and definitions

G. Snow, R. Brakenhoff, B. Braakhuis, 2002 .

A panel of biomarkers of carcinogenesis of the upper aerodigestive tract as potential intermediate endpoints in chemoprevention trials

G. Snow, G. V. van Dongen, N. de Vries, 1993, Cancer.

Successful in vitro growth of human head and neck cancer after transplantation in nude mice

G. Snow, B. Braakhuis, G. H. Boerrigter, 2004, Archives of oto-rhino-laryngology.

Noninvasive Molecular Screening for Oral Precancer in Fanconi Anemia Patients

C. R. Leemans, J. Soulier, D. Deeg, 2015, Cancer Prevention Research.

Expression of a folate binding protein in L1210 cells grown in low folate medium.

J. Schornagel, G. Jansen, B. Braakhuis, 1989, Cancer research.

Antitumour activity, toxicity and inhibition of thymidylate synthase of prolonged administration of 5-fluorouracil in mice.

G. Peters, C. L. van der Wilt, H. Pinedo, 1995, European journal of cancer.

In vitro antitumour activity of cis- and trans-5-fluoro-5,6-dihydro-6-alkoxy-uracils; effects on thymidylate synthesis.

G. Peters, C. L. van der Wilt, B. Braakhuis, 1993, British Journal of Cancer.

Nonmalignant Oral Keratinocytes from Patients with Head and Neck Squamous Cell Carcinoma Show Enhanced Metabolism of Retinoic Acid

G. Snow, R. Brakenhoff, J. Cloos, 2002, Oncology.

Preclinical antitumor activity of 5-aza-2′-deoxycytidine agains human head and neck cancer xenografts

G. Snow, B. Braakhuis, M. S. Walsum, 1988, Investigational New Drugs.

G. Snow, N. de Vries, A. Bast, 1995, European journal of cancer.

Fluoropyrimidine metabolism in human head and neck cancer xenografts and murine colon tumors.

G. Peters, H. Pinedo, B. Braakhuis, 1989 .

A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen

C. R. Leemans, P. Snijders, M. Pawlita, 2007, International journal of cancer.

Circulating fragments of cytokeratin 19 in patients with head and neck squamous cell carcinoma.

G. Snow, V. Bongers, B. Braakhuis, 1995, Clinical otolaryngology and allied sciences.

Head and Neck: Editorial

J. J. Coleman, S. Ariyan, L. Delclos, 2001 .

Molecular characterization of p16‐immunopositive but HPV DNA‐negative oropharyngeal carcinomas

M. Rietbergen, C. R. Leemans, P. Snijders, 2014, International journal of cancer.

Immortalization of oral keratinocytes by functional inactivation of the p53 and pRb pathways

R. Brakenhoff, B. Braakhuis, R. Steenbergen, 2011, International journal of cancer.

The potential of the nude mouse xenograft model for the study of head and neck cancer

G. Snow, B. Braakhuis, G. Sneeuwloper, 2004, Archives of oto-rhino-laryngology.

A noninvasive genetic screening test to detect oral preneoplastic lesions

Elisabeth Bloemena, Arjen Brink, C. R. Leemans, 2005, Laboratory Investigation.

Deoxycytidine kinase and deoxycytidine deaminase activities in human tumour xenografts.

G. Peters, B. Braakhuis, J. Vermorken, 1993, European journal of cancer.

Antitumor activity of brequinar sodium (Dup-785) against human head and neck squamous cell carcinoma xenografts.

G. Peters, G. Snow, G. V. van Dongen, 1990, Cancer letters.

Chemosensitivity of human head and neck cancer xenografts in the clonogenic assay and in nude mice.

G. Snow, B. Braakhuis, G. H. Boerrigter, 1986, British Journal of Cancer.

A simple and reliable technique for culturing of human oral keratinocytes and fibroblasts.

G. Snow, J. Cloos, B. Braakhuis, 1997, Acta oto-laryngologica.

Expanding fields of genetically altered cells in head and neck squamous carcinogenesis.

C. R. Leemans, R. Brakenhoff, B. Braakhuis, 2005, Seminars in cancer biology.

Persistence of genetically altered fields in head and neck cancer patients: biological and clinical implications.

C. R. Leemans, G. Snow, P. Snijders, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

Biologic implications of genetic changes in head and neck squamous cell carcinogenesis.

G. Snow, R. Brakenhoff, B. Braakhuis, 1997, The Australian and New Zealand journal of surgery.

Genomic profiling identifies common HPV-associated chromosomal alterations in squamous cell carcinomas of cervix and head and neck

C. R. Leemans, C. Meijer, P. Snijders, 2009, BMC Medical Genomics.

Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus.

C. R. Leemans, C. Meijer, P. Snijders, 2004, Journal of the National Cancer Institute.

Imaging , Diagnosis , Prognosis Prognostic Significance of Truncating TP 53 Mutations in Head and Neck Squamous Cell Carcinoma

C. R. Leemans, P. Snijders, D. Kuik, 2011 .

Head and Neck Squamous Cell Carcinoma Mutations in TP 53 Prognostic Significance of Truncating

C. R. Leemans, P. Snijders, D. Kuik, 2011 .

Functional Genetic Screens Identify Genes Essential for Tumor Cell Survival in Head and Neck and Lung Cancer

Ruud H. Brakenhoff, Remco Nagel, Sanne R. Martens-de Kemp, 2013, Clinical Cancer Research.

Survival in Head and Neck and Lung Cancer Functional Genetic Screens Identify Genes Essential for Tumor Cell

Remco Nagel, R. Brakenhoff, B. Braakhuis, 2013 .

Simultaneous analysis of retinol, all-trans- and 13-cis-retinoic acid and 13-cis-4-oxoretinoic acid in plasma by liquid chromatography using on-column concentration after single-phase fluid extraction.

B. Braakhuis, T. Teerlink, I. Klaassen, 1997, Journal of chromatography. B, Biomedical sciences and applications.

Genetic Classification of Oral and Oropharyngeal Carcinomas Identifies Subgroups with a Different Prognosis

C. R. Leemans, M. A. van de Wiel, B. Ylstra, 2009, Cellular oncology : the official journal of the International Society for Cellular Oncology.

Microarray Analysis of Bleomycin-Exposed Lymphoblastoid Cells for Identifying Cancer Susceptibility Genes

C. R. Leemans, B. Ylstra, R. Brakenhoff, 2006, Molecular Cancer Research.

Chemotherapy of human head and neck cancer xenografts with three clinically active drugs: cis-platinum, bleomycin and methotrexate.

G. Snow, B. Braakhuis, E. Schoevers, 1983, British Journal of Cancer.

Phase II preclinical drug screening in human tumor xenografts: a first European multicenter collaborative study.

O. Fodstad, S. Langdon, H. Fiebig, 1992, Cancer research.

p53 expression above the basal cell layer in oral mucosa is an early event of malignant transformation and has predictive value for developing oral squamous cell carcinoma

G. Snow, C. Meijer, J. Walboomers, 1998, The Journal of pathology.

Inherited susceptibility to bleomycin-induced chromatid breaks in cultured peripheral blood lymphocytes.

D. Boomsma, G. Snow, D. Kuik, 1999, Journal of the National Cancer Institute.

Loss of heterozygosity at 9p and p53 immunopositivity in surgical margins predict local relapse in head and neck squamous cell carcinoma

C. R. Leemans, D. Kuik, E. Bloemena, 2011, International Journal of Cancer.

A genetic progression model of oral cancer: current evidence and clinical implications.

C. R. Leemans, R. Brakenhoff, B. Braakhuis, 2004, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

Molecular events in relapsed oral squamous cell carcinoma: Recurrence vs. secondary primary tumor.

L. Kowalski, P. Strojan, R. Brakenhoff, 2015, Oral oncology.

Generation of precursor cell lines from preneoplastic fields surrounding head and neck cancers

C. R. Leemans, E. Bloemena, R. Brakenhoff, 2013, Head & neck.

A genome-wide siRNA screen identi ies the FA / BRCA pathway as the strongest predictor of cisplatin response in head and neck cancer cells

D. Kuik, R. Brakenhoff, B. Braakhuis, 2014 .

Moving towards personalised therapy in head and neck squamous cell carcinoma through analysis of next generation sequencing data.

C. Bradford, R. Brakenhoff, M. Giefing, 2016, European journal of cancer.

Genetic susceptibility to head and neck squamous cell carcinoma.

Carlos Suárez, Robert P Takes, E. Sturgis, 2014, International journal of radiation oncology, biology, physics.

Exfoliated oral cell messenger RNA: suitability for biomarker studies.

G. Snow, R. Brakenhoff, B. Braakhuis, 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

TSLC1 gene silencing in cervical cancer cell lines and cervical neoplasia.

C. Meijer, P. Snijders, P. Stern, 2004, Journal of the National Cancer Institute.

The interval between methotrexate and leucovorin determines the efficacy of 5-fluorouracil modulation in vitro and in vivo.

G. Peters, C. L. van der Wilt, H. Pinedo, 1993, Advances in experimental medicine and biology.

Importance of pharmacodynamics in the in vitro antiproliferative activity of the antifolates methotrexate and 10-ethyl-10-deazaaminopterin against human head and neck squamous cell carcinoma.

G. Jansen, B. Braakhuis, P. Noordhuis, 1993, Biochemical pharmacology.

Molecular diagnosis of minimal residual disease in head and neck cancer patients

H. Tanke, C. R. Leemans, R. de Bree, 2012, Cellular Oncology.

Human lymphoblastoid proteome analysis reveals a role for the inhibitor of acetyltransferases complex in DNA double-strand break response.

A. Heck, M. Slijper, R. Brakenhoff, 2006, Cancer research.

Standardization of counting micronuclei: definition of a protocol to measure genotoxic damage in human exfoliated cells.

J. Baak, G. Snow, J. Beliën, 1995, Carcinogenesis.

Genetic susceptibility to head and neck squamous cell carcinoma.

H Tobi, M. Spitz, H. Tobi, 1996, Journal of the National Cancer Institute.

Chapter 5 Identiiication of Lethal Micrornas Speciiic for Head and Neck Cancer

C. R. Leemans, R. Agami, B. Ylstra, 2014 .

Cancer Therapy : Preclinical Identi fi cation of Lethal microRNAs Speci fi c for Head and Neck Cancer

R. Agami, B. Ylstra, R. Brakenhoff, 2013 .

In vitro antiproliferative activity of docetaxel (Taxotere), paclitaxel (Taxol) and cisplatin against human tumour and normal bone marrow cells.

M. Dietel, M. Aapro, B. Hill, 1994, Anticancer research.

Comparative study of the sensitivity of head and neck cell lines to methotrexate (MTX) and the analog 10-ethyl, 10-deazaaminopterin (10-EdAM)

G. Snow, G. V. van Dongen, B. Braakhuis, 1990, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

Lack of effect of methotrexate on human head and neck tumours transplanted in athymic nude mice.

G. Snow, J. Schornagel, B. Braakhuis, 1985, Acta oto-laryngologica.

Incidence and survival trends of head and neck squamous cell carcinoma in the Netherlands between 1989 and 2011.

C. R. Leemans, O. Visser, B. Braakhuis, 2014, Oral oncology.

Assessment of chromosomal gains and losses in oral squamous cell carcinoma by comparative genomic hybridisation.

J. Baak, H. Joenje, M. Hermsen, 1997, Oral oncology.

Genome-wide DNA copy number alterations in head and neck squamous cell carcinomas with or without oncogene-expressing human papillomavirus

P J F Snijders, C. R. Leemans, P. Snijders, 2006, Oncogene.

Gene expression profiling in head and neck squamous cell carcinoma

C. R. Leemans, R. Brakenhoff, B. Braakhuis, 2010, Current opinion in otolaryngology & head and neck surgery.

Expression profiling and prediction of distant metastases in head and neck squamous cell carcinoma

C. R. Leemans, B. Ylstra, D. Kuik, 2006, Journal of Clinical Pathology.

Interaction of quantitative 18F‐FDG‐PET‐CT imaging parameters and human papillomavirus status in oropharyngeal squamous cell carcinoma

R. Boellaard, O. Hoekstra, R. de Bree, 2016, Head and Neck.

Quantitative Diffusion-Weighted MRI Parameters and Human Papillomavirus Status in Oropharyngeal Squamous Cell Carcinoma

C. R. Leemans, R. de Bree, E. Bloemena, 2015, American Journal of Neuroradiology.

Interaction between cisplatin and gemcitabine in vitro and in vivo.

G. Peters, A. Bergman, B. Braakhuis, 1995, Seminars in oncology.

Influence of the antioxidant N-acetylcysteine and its metabolites on damage induced by bleomycin in PM2 bacteriophage DNA.

G. Snow, J. Cloos, B. Braakhuis, 1996, Carcinogenesis.

Activity of Six New Drugs in Head and Neck Cancer Xenografts

G. Snow, H. Pinedo, B. Braakhuis, 1988 .

Carcinoembryonic antigen and head and neck cancer.

G. Snow, B. Braakhuis, G. V. van Kamp, 1991, Clinical otolaryngology and allied sciences.

Surgical margins in head and neck cancer: Intra- and postoperative considerations.

R. de Bree, J. Hunt, L. Kowalski, 2019, Auris, nasus, larynx.

CD98 marks a subpopulation of head and neck squamous cell carcinoma cells with stem cell properties.

M. Slijper, F. Rustenburg, W. V. van Wieringen, 2013, Stem cell research.

Comparison of bleomycin and radiation in the G2 assay of chromatid breaks

P. Bryant, R. Verheijen, J. Cloos, 2003, International journal of radiation biology.

Association between bleomycin genotoxicity and non-constitutional risk factors for head and neck cancer.

G. Snow, N. de Vries, H. Joenje, 1993, Cancer letters.

Targeting PLK1 as a novel chemopreventive approach to eradicate preneoplastic mucosal changes in the head and neck

C. R. Leemans, E. Bloemena, Sanne R. Martens-de Kemp, 2017, Oncotarget.

Differential Proteomics Identifies Protein Biomarkers That Predict Local Relapse of Head and Neck Squamous Cell Carcinomas

C. R. Leemans, A. Heck, M. Slijper, 2009, Clinical Cancer Research.

Comparative evaluation of genetic assays to identify oral pre-cancerous fields.

C. R. Leemans, D. Kuik, G. Meijer, 2008, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

Effect of cisplatin exposure on platinum accumulation and growth inhibition in human neoplastic and normal squamous epithelial cells of the mucosa of the upper-aerodigestive tract.

M. Welters, J. Cloos, B. Braakhuis, 1999, Cancer letters.

Effects of ADTN and various other 2-aminotetralin derivatives on the efflux of 3H-dopamine from rat striatal slices.

B. Braakhuis, A. H. Mulder, D. Dijkstra, 1980, European journal of pharmacology.

Transplantability of human head and neck squamous cell carcinomas in athymic nude mice.

G. Snow, G. V. van Dongen, M. van Walsum, 1989, Archives of otolaryngology--head & neck surgery.

Abstract 338: Truncating TP53 mutations have prognostic significance in head and neck squamous cell carcinoma

C. R. Leemans, P. Snijders, D. Kuik, 2011 .

Pharmacodynamics of cisplatin in human head and neck cancer: correlation between platinum content, DNA adduct levels and drug sensitivity in vitro and in vivo

M. Welters, R. Baan, B. Braakhuis, 1999, British Journal of Cancer.

Molecular Detection of Minimal Residual Cancer in Surgical Margins of Head and Neck Cancer Patients

C. R. Leemans, R. de Bree, M. de Maaker, 2009, Cellular oncology : the official journal of the International Society for Cellular Oncology.